Moberg Pharma AB (publ)
STO:MOB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
STO:MOB
|
SE |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
F
|
Fuji Electric Co Ltd
XMUN:FJE
|
JP |
|
Multipolar Technology Tbk PT
IDX:MLPT
|
ID |
|
C
|
Carabao Group PCL
SET:CBG
|
TH |
|
X
|
Xometry Inc
NASDAQ:XMTR
|
US |
|
C
|
Constellation Software Inc
XMUN:W9C
|
CA |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
Wall St Price Targets
MOB Price Targets Summary
Moberg Pharma AB (publ)
According to Wall Street analysts, the average 1-year price target for MOB is 16.32 SEK with a low forecast of 16.16 SEK and a high forecast of 16.8 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOB's stock price target?
Price Target
16.32
SEK
According to Wall Street analysts, the average 1-year price target for MOB is 16.32 SEK with a low forecast of 16.16 SEK and a high forecast of 16.8 SEK.
What is the Revenue forecast for Moberg Pharma AB (publ)?
Projected CAGR
92%
The compound annual growth rate for Revenue over the next 3 years is 92%.
What is the Gross Profit forecast for Moberg Pharma AB (publ)?
Projected CAGR
107%
The compound annual growth rate for Gross Profit over the next 3 years is 107%.
